Navigation Links
Newborns' Cerebral Palsy Risk Increased By Alzheimer's Gene

nnual economic toll on society estimated at $5 billion and is the most costly of the clinically significant birth defects in the United States.

Cerebral palsy encompasses a diverse group of disorders characterized by non-progressive impairment of motor function resulting from injury to the developing brain. Cerebral palsy is often associated with impaired intellectual function, sensory deficits, behavioral disorders and seizures. In the majority of cases, a specific cause for cerebral palsy cannot be identified.

The protein apoE that is coded by the APOE gene is produced in the brain, where it plays multiple roles, including protecting against injury. Wainwright said that the contribution of the APOE gene to susceptibility to neurologic injury might vary with age and the nature of the brain injury.

"People who carry the E4 allele may not be able to recover as effectively from a brain injury, making these newborns at greater risk for developing cerebral palsy," he said.

Wainwright hopes to conduct additional studies to confirm these findings in other populations and to evaluate the role of the apoE protein in specific biochemical pathways in the brain for development of cerebral palsy after perinatal brain injury.

Source-Eurekalert
SRI
'"/>




Page: 1 2

Related medicine news :

1. Genetic Disorders, Not Fetal Distress Increase Cerebral Palsy Risk
2. Viral Infection At Birth Leads To Cerebral Palsy.
3. Mystery Killer Disease In Nepal Diagnosed As Cerebral Malaria
4. Genetic Disorders, Not Fetal Distress Increase Cerebral Palsy Risk
5. Viral Infection At Birth Leads To Cerebral Palsy.
6. Use of Cellular Phones associated with Increased risk of Brain Tumors
7. Increased Heart Attack Risk From Celebrex,Vioxx
8. Allergy Risk Increased by Kerosene Use
9. Fewer teeth & Increased Ischemic Stroke risk
10. Young Smokers at Increased Risk Of Developing a Heart Attack
11. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...a study in the August issue of their journal, Diab...s more effective in treating// type-2 diabetes tha...en better than single agent therapy with oral diab... markers; blood sugar control, cholesterol reducti...
...tal information to the surgeon on the extent of ti...lable to complete the procedure// has been develop...ns to work on actively beating heart, while having...ing during surgery, making the surgical interventi...
...nter in Salt Lake City have successfully separated... Herrin,// after a 16-hour surgery. Doctors prono...bodies joined at the abdomen successful, but cauti...ery period and would have to undergo extensive rec...
...s carry a "warrior" gene which make them more pron...terming such claims// as dangerous and inflammator...epidemiologist at Environmental Science and Resear...i men have a "striking over-representation" of mon...
Other Medicine News:Health News:Triple-Monitoring System To Monitor Heart Viability During Surgery 2Health News:Successful Separation Of Conjoined Twins 2Health News:Warrior Gene Claims Slammed by Maori 2Health News:Warrior Gene Claims Slammed by Maori 3
(Date:9/3/2008)... Repeat-Dosing Study in Subjects with ALS, RICHMO...amo,BioSciences, Inc. (Nasdaq: SGMO ) announced t...SB-509-801) to evaluate its drug, SB-509, in subje...uron disease for which there,are limited treatment... an injectable formulation of a plasmid,encoding a...
(Date:9/2/2008)...ire-FirstCall/ -- Forest Laboratories, Inc.,(NYSE:...unced results from,two global Phase III studies of...nticholinergic for the treatment of patients with ...oth the ACCLAIM/COPD I&II,(AClidinium CLinical Tri...vere COPD Patients) studies, once-daily aclidinium...
(Date:9/2/2008)...ision, ONE to Build Hope and Give Help, MINNEAPOL...o the,Republican Party Convention are sending a me...e world including evacuees in the Gulf Coast regio...ing countries: "We are here,to help.", World Visi...es to do,something unconventional. This event prov...
(Date:9/2/2008)...PRNewswire-USNewswire/ -- An annual program,that h... western,Pennsylvania, Agriculture Secretary Denni...baiting program covers all or parts of,Allegheny, ..., Greene,Indiana, Lawrence, Mercer, Venango, Wash...he spread of rabies in wild animals is essential t...
Breaking Medicine Technology:Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 2Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 3Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 4Rabies Vaccination Program Underway in Western Pennsylvania 2Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 1Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 2Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 3Merrimack Pharmaceuticals Announces the Addition of Robert Gay to its Board of Directors 2009 1Merrimack Pharmaceuticals Announces the Addition of Robert Gay to its Board of Directors 2009 2Merrimack Pharmaceuticals Announces the Addition of Robert Gay to its Board of Directors 2009 3New treatment for age related macular degeneration within sight 1391 1New treatment for age related macular degeneration within sight 1391 2Fewer Women Getting Mammograms 7218 1Fewer Women Getting Mammograms 7218 2Fewer Women Getting Mammograms 7218 3
...mise as Future-Generation,Technology, BARCELONA, S...t,today announced positive results from ABSORB, th...ty and performance of a fully,bioabsorbable drug e...y artery disease. Nine-month results from the firs... EuroPCR meeting,demonstrated no stent thrombosis...
...irstCall/ -- According to,study results presented ... annual meeting, iloperidone, an investigational,a...le akathisia,profile. Akathisia -- a debilitating ...bility to sit still -- is a frequent side effect,o...studied by Vanda,Pharmaceuticals Inc. , a biopharm...
Other Medicine Technology:Abbott Announces Positive Nine-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 2Abbott Announces Positive Nine-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 3Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 2Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 3Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 4Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 5
ULTRAMER Foley Catheter
Coude Foley Catheters (Latex) 2-Way Amber
Silicone-Coated Foley Catheter 2-Way
Silicone Elastomer-Coated Latex Foley Catheters 3-Way
Medicine Products: